Roivant Sciences Ltd. (ROIV) has a market capitalization of $20.84B and trades at $29.12. The 52-week range is 8.73-30.33.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -122.8, Earnings Per Share (EPS) of $-0.24, annual revenue of $29.05M.
The stock has a beta of 1.21, operates in the Healthcare sector.
